Current stock page

Catalysts

ILMN Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - Diagnostics & ResearchScore data as of Oct 30, 2026

ILMNIllumina, Inc.

Healthcare / Medical - Diagnostics & Research

Low Priority

In Line With Peers

NeutralEdge 5/10
$235.99−$54.07 (−18.64%)

Latest quote

  • Momentum
    69
  • Value
    26
  • Quality
    78
  • Risk resilience
    38
  • Sentiment
    —
algovestiq.comScore data as of Oct 30, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 4, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 54/100

Momentum 69/100 and sentiment — before the next covered event.

Recent coverage
0 articles

Updated — · Sentiment not scored

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 69/100AIQ Edge 5/10 In Line With Peers
Beat rate
100%
5 of 5 reported periods
Average surprise
+11.7%
Across covered historical reports
Latest result
+19.1%
Oct 29, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Oct 29, 2026—$1.36$1.62+19.1%$1.15B$1.17B
Jul 30, 2026—$1.23$1.31+6.5%$1.13B$1.16B
Apr 30, 2026—$1.05$1.15+9.5%$1.07B$1.09B
Feb 5, 2026—$1.24$1.35+8.9%$1.12B$1.16B
Oct 30, 2025—$1.17$1.34+14.5%$1.07B$1.08B

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Hold
11
Buy
7
Hold
4
Sell
12-month analyst target
$225.30
-4.53% versus current price
Based on 11 analyst observations. Targets are estimates, not predictions.
Low target
$155.00
-34.32% vs latest price
Average target
$225.30
-4.53% vs latest price
High target
$305.00
+29.24% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 4, 2027

Next known earnings or reporting date.

EPS estimate$1.50

Current analyst expectation for the upcoming report.

Revenue estimate$1.23B

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score69

Where event reaction would show up first.

AIQ score54/100

Composite decision read before event confirmation.

Analyst context

Consensus
Hold
Analysts
11
Average target
$225.30
Target upside
-4.53%
Target range
$155.00 - $305.00
90-day revisions
4

News And Sentiment

Recent company coverage, scored where source sentiment is available.

No recent articles have a scored sentiment label.
Positive
0
Neutral
0
Negative
0

No recent company-specific news is available.

Open full news and sentiment

ILMN Catalysts FAQ

What are the next catalysts for ILMN stock?

ILMN's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move ILMN stock?

Upcoming events that could move ILMN include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could ILMN's next earnings report affect the stock?

ILMN's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive ILMN stock higher?

ILMN could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt ILMN stock?

ILMN could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.